Drug Topics September 20, 2024
In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.
Just days after Cigna’s pharmacy benefit manager (PBM), Express Scripts, filed a lawsuit against the Federal Trade Commission (FTC) for defamation regarding the Commission’s July interim staff report, the FTC countered and filed a lawsuit against the “Big 3” PBMs— CVS Caremark, Express Scripts, and Optum Rx—for using unfair practices to inflate insulin prices.
“Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed,” said Rahul Rao, Deputy Director...